Cancer Aware · Patient & Family Guide

Evidence, Authorship and Review Status

Sources, review limits and the distinction between AI-assisted preparation and physician sign-off.

Educational information for patients and families. This guide supports, but does not replace, individualized medical advice. It cannot diagnose, stage cancer or prescribe treatment.

All 25 chapters

Medical authorship and transparent review

The established Cancer Aware medical-content credit is Dr Hakeem Ansar Hussain, Medical Oncologist. This cervical guide was prepared with AI assistance. Evidence and editorial checking was performed during preparation on 26–28 October 2026. No individual physician sign-off for these newly added pages is recorded; the site does not claim that the clinician has personally checked each sentence.

What was checked

The review focused on FIGO staging boundaries, screening and vaccination differences, fertility and surgical selection, brachytherapy, immunotherapy settings, trial populations and outcomes, and regional regulatory distinctions. Primary trial reports, WHO, Indian government, NCI, FIGO, ESGO/ESTRO/ESP, ASCCP, ACS, USPSTF, HRSA, FDA and EMA sources are linked below and in the relevant chapters.

The current full licensed NCCN and ESMO professional texts were not comprehensively accessed line by line. This guide therefore does not claim complete verification against every October 2026 guideline version or every country's drug label. Treating clinicians should check their current local professional guidance, approvals and reimbursement.

How to read the evidence

Trial efficacy is different from a regulatory indication, and an approval in one jurisdiction is not worldwide approval. Older FIGO trial eligibility must not be relabelled using newer staging without reviewing the actual disease extent. Survival statistics describe populations and cannot give an individual's prognosis. Educational tools do not issue screening orders, assign a clinical stage or prescribe treatment.

Updates and corrections

Clinician review should record the reviewer's name, actual date, scope and any corrections before the review status is changed. New guidance, label changes or errors should trigger revision of both the chapter and linked tool. Publication and an evidence-check date do not constitute physician endorsement of an unreviewed change.

Urgent symptoms

Heavy bleeding with faintness, chest pain, sudden breathlessness, confusion or severe uncontrolled pain requires urgent medical care. Fever during chemotherapy, severe diarrhoea, dehydration or new symptoms on immunotherapy require immediate contact with the treating team. Do not wait for a website response.

References and review status

Evidence/editorial check: 28 October 2026. AI-assisted preparation is separate from physician sign-off. Individual physician review is not recorded. Local approvals, resources and clinical guidance must be confirmed by the treating team.

Evidence scope and update policy